TopNewsToday.org
»
»
»

Bayer says drug shows promise vs. gastrointestinal cancer

yahoo.com (2 years and 1 month ago)

Jun 4, 2012

FRANKFURT (Reuters) - German drugmaker Bayer said trials showed its potential blockbuster regorafenib prolonged the lives of patients with an aggressive type of gastrointestinal cancer without their tumors worsening, and it will seek approval for wider use of the drug. The 199-patient late-stage trial showed the drug prolonged the lives of patients with metastatic gastrointestinal stromal tumors, or GIST, by almost four months on average... full story

More news more news

Bayer says drug shows promise vs. gastrointestinal cancer

reuters.com (2 years and 1 month ago)

ASCO 2012 Live Blog -- Monday

thestreet.com (2 years and 1 month ago)

Boehringer plans to challenge lung cancer drugs

yahoo.com (2 years and 1 month ago)

Brendan T. Hoffman’s New Book Began with a Promise

yahoo.com (2 years and 1 month ago)

Cancer drug Avastin slows ovarian cancer progression, study shows

foxnews.com (2 years and 1 month ago)

Boehringer plans to challenge lung cancer drugs

reuters.com (2 years and 1 month ago)

Experimental Roche breast cancer drug slows tumor growth, study shows

foxnews.com (2 years and 1 month ago)

New 'Personalized' Drugs Show Promise Against Melanoma, Lung Cancer

yahoo.com (2 years and 1 month ago)

Casa Vinicola Zonin USA Supports Breast Cancer Awareness Month by Donating $1.00 per Bottle Sold of Zonin Sparkling Rose

yahoo.com (2 years and 1 month ago)

New Cancer Data Shine Spotlight On The Secret Committees That Make Medicine's Toughest Decisions

forbes.com (2 years and 1 month ago)

More Latin America news »

Most read

Most popular

Follow us

Facebook
Twitter
Google+
RSS Feed
US | Sport | Business | Technology | Lifestyle | Entertainment | World | Search
Privacy Policy | About | Contacts
All news and photos belong to their authors.